Sutro Biopharma STRO
NASDAQ STRO
$16.11 +0.01 (+0.06%)
At close: Sep 30, 2026 · 4:00 PM EDT

Sutro Biopharma (STRO) Non-Current Deffered Revenue (2017 - 2025)

Updated

Sutro Biopharma (STRO) recorded Non-Current Deffered Revenue of $2.03 million in Q4 2025, down 83.8% from $12.54 million a year earlier and down 46.0% from the prior quarter.

Analysis

Sutro Biopharma (STRO) Non-Current Deffered Revenue (2017 - 2025) Analysis & Trends

Starting with Q4 2017, Sutro Biopharma's Non-Current Deffered Revenue history includes 29 quarters.

  • Annual Non-Current Deffered Revenue has declined for three straight years, with a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
  • Across earlier years, Non-Current Deffered Revenue came in at $12.54 million in FY2024 (-76.5%), $53.38 million in FY2023 (-40.6%) and $89.89 million in FY2022.
  • The Q4 2025 figure is the lowest quarterly Non-Current Deffered Revenue since Q3 2021.
  • On a year-over-year basis, Non-Current Deffered Revenue has declined for nine consecutive quarters, with an average decline of 73.1% over the last eight quarters.
  • Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 4.6% in Q3 2023, against a decline of 98.3% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.76 million (Q3 2025), $6.91 million (Q2 2025) and $8.57 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Sutro Biopharma 267.04 Mn -411.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.03 Mn
Sep 30, 2025 3.76 Mn
Jun 30, 2025 6.91 Mn
Mar 31, 2025 8.57 Mn
Dec 31, 2024 12.54 Mn
Sep 30, 2024 18.00 Mn
Jun 30, 2024 21.69 Mn
Mar 31, 2024 46.31 Mn
Dec 31, 2023 53.38 Mn
Sep 30, 2023 78.15 Mn
Jun 30, 2023 79.88 Mn
Mar 31, 2023 85.05 Mn
Dec 31, 2022 89.89 Mn
Sep 30, 2022 74.73 Mn
Jun 30, 2022 90.00 Mn
Sep 30, 2021 145,000.00
Jun 30, 2021 193,000.00
Mar 31, 2021 822,000.00
Dec 31, 2020 6.10 Mn
Sep 30, 2020 8.37 Mn
API Access

Sutro Biopharma Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=STRO&period=max&api_key=YOUR_API_KEY